Geneticure
Eden Prairie, US · Founded 2013 · Delaware corporation · 9 employees on LinkedIn · 1 known investors
Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.
Founders & leadership
Geneticure was founded in 2013 by Scott Snyder.
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 3 rounds · 2016–2017
▶$200KraisedApr 2017 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott SnyderExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $200K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$250KraisedOct 2016 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedOct 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott SnyderExecutive Officer
- Offering amount
- $400K
- Amount sold
- $250K
- Minimum investment
- $50K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$665KraisedMay 2016 · 7 investors · Biotechnology
▶$665KraisedMay 2016 · 7 investors · Biotechnology
Officers, directors & promoters on the filing
- SCOTT SNYDERExecutive Officer
- BEN BOWMANExecutive Officer
- ERIC SYNDERExecutive Officer
- RYAN SPRISSLERExecutive Officer
- THOMAS OLSONExecutive Officer
- Offering amount
- $890K
- Amount sold
- $665K
- Minimum investment
- $25K
- First sale
- Mar 2016
- Incorporated
- Limited Liability Company, Minnesota, 2013
- Federal exemptions
- 04.1
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapQuest Diagnostics28 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Genomind27 shared keywordsGenomind provides pharmacogenetic testing and precision medicine software to help healthcare providers tailor medication prescriptions based on patients' genetic profiles, lifestyle, and environment. The platform integrates genetic data with clinical expertise to reduce adverse drug events and improve treatment outcomes across individual and population health settings.
Labcorp24 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Self Decode17 shared keywordsSelfDecode is a consumer genomics platform that analyzes users' DNA, blood test results, and lifestyle data to generate 1,500+ personalized health reports and AI-driven recommendations on diet, supplements, and lifestyle. It sells DNA test kits and subscription access to tools including an AI health assistant (DecodyGPT) and lab analysis, serving consumers, doctors, and businesses.
23andMe16 shared keywords23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery. The company enables individuals to learn about their genetic traits while contributing to medical research studies that benefit public health.
Companies competing with Geneticure for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Geneticure do?
- Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.
- Who founded Geneticure?
- Geneticure was founded by Scott Snyder in 2013.
- Who are Geneticure's investors?
- Geneticure's investors include Wireframe Ventures.
- How much funding has Geneticure raised?
- Geneticure has disclosed $1.1M raised across 3 rounds.
- Where is Geneticure headquartered?
- Geneticure is headquartered in Eden Prairie, US.